Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PainReform (PRFX)
NASDAQ:PRFX
PainReform (PRFX) Stock Price & Analysis
69 Followers
PRFX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.69 - $26.41
Previous Close$0.78
Volume64.12K
Average Volume (3M)147.27K
Market Cap
$1.93M
Enterprise Value-$5.76M
Total Cash (Recent Filing)$8.03M
Total Debt (Recent Filing)$337.00K
Price to Earnings (P/E)-0.1
Beta0.89
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.65
Shares Outstanding1,728,347
10 Day Avg. Volume27,930
30 Day Avg. Volume147,271
Standard Deviation0.20
R-Squared0.03
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)0.19
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit5.75
Enterprise Value/Ebitda1.46
Forecast
1Y Price Target
$11.00Price Target Upside1241.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
PainReform News
PremiumCompany Announcements
PainReform Ltd. Adjusts Warrant Terms
PremiumCompany Announcements
PainReform Ltd. Launches $4 Million Public Offering
PremiumCompany Announcements
PainReform’s PRF-110 Sets New Pain Relief Benchmark
Ownership Overview
0.00%
Insiders
0.08% Mutual Funds
6.87% Other Institutional Investors
93.05% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PRFX FAQ
What was PainReform’s price range in the past 12 months?
PainReform lowest stock price was $0.69 and its highest was $26.41 in the past 12 months.
What is PainReform’s market cap?
Currently, no data Available
When is PainReform’s upcoming earnings report date?
PainReform’s upcoming earnings report date is Aug 13, 2024 which is in 91 days.
How were PainReform’s earnings last quarter?
Currently, no data Available
Is PainReform overvalued?
According to Wall Street analysts PainReform’s price is currently Undervalued.
Does PainReform pay dividends?
PainReform does not currently pay dividends.
What is PainReform’s EPS estimate?
PainReform’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PainReform have?
PainReform has 2,473,743 shares outstanding.
What happened to PainReform’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PainReform?
Currently, no hedge funds are holding shares in PRFX
---
PainReform Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.00 (1241.46% Upside)
$11.00 (1241.46% Upside)
Blogger Sentiment
Bullish
PRFX Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-87.55%
12-Months-Change
Fundamentals
Return on Equity
-102.34%
Trailing 12-Months
Asset Growth
-19.45%
Trailing 12-Months
Company Description
PainReform
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
---
PRFX Stock 12 Month Forecast
Average Price Target
$11.00
▲(1241.46% Upside)
Technical Analysis
Best Analysts Covering PRFX
1 Year
1 Year Success Rate
0/12 ratings generated profit
1 Year Average Return
-64.82%
reiterated a buy rating last month
Copying Naz Rahman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -64.82% per trade.
---